Results 241 to 250 of about 1,353,059 (301)

The Evolving Landscape of Pulmonary Hypertension Treatment: From Vasodilation to Disease Modification. [PDF]

Clin Transl Sci
Ayalasomayajula S, Bajwa EK, Cornell AG, Loureiro MJ, Kim SS, DiBello JR, Sterner E, Chen R, Younis IR.   +8 more
europepmc   +1 more source

Incident heart failure: comparing management and outcome in primary and hospital settings in Western Sweden 2008–2017

ESC Heart Failure, Volume 12, Issue 2, Page 832-838, April 2025.
Abstract Aim Heart failure (HF) is a highly prevalent condition managed in both primary care (PC) and hospital care (HC)‐based settings. HF patients managed in these two settings may differ in their demography, comorbidities and outcomes, so we aimed to compare the patient management in PC and HC in the Västra Götaland Region (VGR) in Sweden.
Xiaojing Chen, Aldina Pivodic, Maria Schaufelberger, Annika Rosengren, Michael Fu   +4 more
wiley   +1 more source

Lifelong hypoxia produces multigenerational developmental lung disease and pulmonary hypertension in mice. [PDF]

Am J Physiol Lung Cell Mol Physiol
Zazzeron L, Tattersfield H, Moore E, Xiao X, Marutani E, Li H, Ichinose F.   +6 more
europepmc   +1 more source

Comprehensive exploration of unexplained dyspnoea in subjects with normal ejection fraction and low natriuretic peptides

ESC Heart Failure, Volume 12, Issue 2, Page 879-887, April 2025.
Abstract Background Unexplained exertional dyspnoea without significant elevation of natriuretic peptides is common. One of the causes might be early heart failure with preserved ejection fraction (HFpEF). Aims This study aimed to characterize patients with exertional dyspnoea and normal/near‐to‐normal N‐terminal pro‐brain natriuretic peptide (NT ...
Emmanuelle Berthelot, Tarek Laouar, Antoine Beurnier, Nataliya Hrynchynshyn, Jean Christophe Eicher, Jean‐Michel Tartière, Patrick Jourdain, Olivier Lairez, Barnabas Gellen   +8 more
wiley   +1 more source

Pulmonary Hypertension Following the Use of Trastuzumab Biosimilars. [PDF]

Case Rep Pulmonol
Ojo T, Cablay K, Emara N, Meyer A.
europepmc   +1 more source

Unveiling the Link Between COVID-19 and Pulmonary Hypertension. [PDF]

Can J Infect Dis Med Microbiol
Abdul Khalek J, Al Hajjar M, Al-Khalil Z, Salem J, Zareef R, Bitar F, Arabi M.   +6 more
europepmc   +1 more source

The in‐hospital administration of sacubitril/valsartan in acute myocardial infarction: A meta‐analysis

ESC Heart Failure, Volume 12, Issue 2, Page 998-1012, April 2025.
In patients with Acute Myocardial Infarction related heart failure, the in‐hospital administration of ARNIs was associated with a reduced risk of MACEs and re‐hospitalizations for heart failure, as well as cardiac remodeling, compared to standard therapy.
Gianluca Di Pietro, Riccardo Improta, Paolo Severino, Andrea D'Amato, Lucia Ilaria Birtolo, Ovidio De Filippo, Antonio Lattanzio, Raffaele De Cristofaro, Giacchino Galardo, Fabrizio D'Ascenzo, Roberto Badagliacca, Gennaro Sardella, Maurizio Volterrani, Francesco Fedele, Carmine Dario Vizza, Massimo Mancone   +15 more
wiley   +1 more source

Diagnostic and management dilemmas in pulmonary hypertension. [PDF]

Eur Respir Rev
Condliffe R, Aman J, Boucly A, Cerrone E, Jutant EM, Kovacs G, Meijboom LJ, Olsson KM, Park DH, Seferian A, Sitbon O, Vachiery JL, Vonk Noordegraaf A, Montani D, Nossent EJ.   +14 more
europepmc   +1 more source

Differences in Chronic Pulmonary Embolism Burden in Chronic Thromboembolic Disease with and Without Pulmonary Hypertension. [PDF]

J Clin Med
McQuade C, Davoudi D, Lajkosz K, Donahoe L, Granton J, Perrot M, McInnis M.   +6 more
europepmc   +1 more source

Commonalities of platelet dysfunction in heart failure with preserved ejection fraction and underlying comorbidities

ESC Heart Failure, Volume 12, Issue 2, Page 1013-1028, April 2025.
Abstract Heart failure with preserved ejection fraction (HFpEF) is characterized by a lack of a specific targeted treatment and a complex, partially unexplored pathophysiology. Common comorbidities associated with HFpEF are hypertension, atrial fibrillation, obesity and diabetes.
Giorgia D'Italia, Blanche Schroen, Judith M.E.M. Cosemans   +2 more
wiley   +1 more source